Brainstorm Cell Therapeutics Inc. (BCLI)
SG&A Expenses
$696.00K
TTM · Period ending: · USD
BCLI SG&A Expenses
Latest reported$696.00Kperiod ending
Latest reported$696.00Kperiod ending
BCLI TTM SG&A Expenses ($31.69K → $696.00K)
TTM SG&A Expenses
High-resolution chart · PNG
BCLI sg&a expenses history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | SG&A Expenses (USD) |
|---|---|
| 696,000 | |
| -501,000 | |
| 0 | |
| 5,852,000 | |
| 6,707,000 | |
| 7,314,000 | |
| 7,042,000 | |
| 8,682,000 | |
| 9,384,000 | |
| 9,979,000 | |
| 10,693,000 | |
| 10,051,000 | |
| 10,411,000 | |
| 10,234,000 | |
| 10,866,000 | |
| 10,937,000 | |
| 9,531,000 | |
| 9,575,000 | |
| 9,304,000 | |
| 9,440,000 | |
| 10,399,000 | |
| 9,583,000 | |
| 9,355,000 | |
| 8,163,000 | |
| 7,088,000 | |
| 6,685,000 | |
| 5,797,000 | |
| 5,895,000 | |
| 5,609,000 | |
| 5,912,000 | |
| 5,770,000 | |
| 5,522,000 | |
| 5,489,000 | |
| 4,523,000 | |
| 4,022,000 | |
| 3,020,000 | |
| 2,644,000 | |
| 2,836,000 | |
| 2,833,000 | |
| 3,077,000 | |
| 3,297,000 | |
| 3,453,000 | |
| 3,587,000 | |
| 4,041,000 | |
| 3,831,000 | |
| 3,260,000 | |
| 2,651,000 | |
| 2,153,000 | |
| 1,567,000 | |
| 1,893,000 | |
| 2,101,000 | |
| 1,925,000 | |
| 2,093,000 | |
| 1,798,000 | |
| 1,749,000 | |
| 2,144,000 | |
| 2,268,000 | |
| 2,649,000 | |
| 2,397,000 | |
| 2,293,000 | |
| 1,993,000 | |
| 1,432,000 | |
| 1,544,000 | |
| 1,588,000 | |
| 1,642,000 | |
| 1,688,000 | |
| 1,569,000 | |
| 1,084,000 | |
| 1,171,000 | |
| 1,336,000 | |
| 1,629,000 | |
| 2,348,000 | |
| 2,808,000 | |
| 2,786,000 | |
| 2,989,811 | |
| 3,347,313 | |
| 3,103,313 | |
| 3,278,623 | |
| 3,163,122 | |
| 2,460,464 | |
| 2,544,060 | |
| 2,454,058 | |
| 2,324,095 | |
| 2,051,957 | |
| 2,921,995 | |
| 2,388,385 | |
| 1,913,161 | |
| 1,619,124 | |
| 49,598 | |
| 47,233 | |
| 31,688 | |
| 34,827 | |
| 37,324 | |
| 36,424 |